In Bacterial infections Lyotaz 2000 mg/250 mg Injection contains two different medicines that work together to kill the bacteria that cause infections. Piperacillin belongs to a group of medicines called penicillins that work by stopping the growth of bacteria. Tazobactam is a beta-lactamase inhibitor that reduces resistance and enhances the activity of Piperacillin against bacteria. Lyotaz 2000 mg/250 mg Injection can be used to treat many different bacterial infections such as ear, sinus, throat, lung, urinary tract, skin, teeth, joints, and bones. This medicine usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
Consuming alcohol with Lyotaz 2000 mg/250 mg Injection does not cause any harmful side effects.
Lyotaz 2000 mg/250 mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Lyotaz 2000 mg/250 mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
It is not known whether Lyotaz 2000 mg/250 mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Lyotaz 2000 mg/250 mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Lyotaz 2000 mg/250 mg Injection may be needed. Please consult your doctor.
Lyotaz 2000 mg/250 mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Lyotaz 2000 mg/250 mg Injection may not be needed in these patients. Please consult your doctor.
If you miss a dose of Lyotaz 2000 mg/250 mg Injection, please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Fusion Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Hetero Drugs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Aareen Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zoom Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Macleods Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Chandra Bhagat Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Mankind Pharma Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alcott Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Novo Medi Sciences Pvt Ltd || ₹14.5/tablet (25% cheaper)